COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Sevasti Karaliota
Institution
National Cancer Institute
Address
Frederick
Maryland
United States
vCard
Download vCard
Publication Timeline
COVID-19 publications
All Publications
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To see the data from both graphs as text,
click here
.
Year
Publications
2003
1
2009
2
2016
1
2018
4
2019
1
2021
3
These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.
To return to the graphs,
click here
.
Publication Field Summary
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text,
click here
.
Publication List
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Show:
All coronarirus related publications
|
Covid-19 specific publications
|
All publications
Sort By:
Newest
|
Oldest
|
Most Cited
|
Most Discussed
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Bergamaschi C
,
Terpos E
,
Rosati M
,
Angel M
,
Bear J
,
Stellas D
,
Karaliota S
,
Apostolakou F
,
Bagratuni T
,
Patseas D
,
Gumeni S
,
Trougakos IP
,
Dimopoulos MA
,
Felber BK
,
Pavlakis GN
. Systemic IL-15, IFN-?, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients. Cell Rep. 2021 08 10; 36(6):109504.
PMID:
34352226
.
Citations:
5
Fields:
Cel
Cell Biology
Mol
Molecular Biology
Translation:
Humans
Terpos E
,
Stellas D
,
Rosati M
,
Sergentanis TN
,
Hu X
,
Politou M
,
Pappa V
,
Ntanasis-Stathopoulos I
,
Karaliota S
,
Bear J
,
Donohue D
,
Pagoni M
,
Grouzi E
,
Korompoki E
,
Pavlakis GN
,
Felber BK
,
Dimopoulos MA
. SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors. Eur J Intern Med. 2021 07; 89:87-96.
PMID:
34053848
.
Citations:
9
Fields:
Int
Internal Medicine
Translation:
Humans
CT
Clinical Trials
Pappa V
,
Bouchla A
,
Terpos E
,
Thomopoulos TP
,
Rosati M
,
Stellas D
,
Antoniadou A
,
Mentis A
,
Papageorgiou SG
,
Politou M
,
Kotanidou A
,
Kalomenidis I
,
Poulakou G
,
Jahaj E
,
Korompoki E
,
Grigoropoulou S
,
Hu X
,
Bear J
,
Karaliota S
,
Burns R
,
Pagoni M
,
Trontzas I
,
Grouzi E
,
Labropoulou S
,
Stamoulis K
,
Bamias A
,
Tsiodras S
,
Felber BK
,
Pavlakis GN
,
Dimopoulos MA
. A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis. Microorganisms. 2021 Apr 11; 9(4).
PMID:
33920489
.
Citations:
4
Start with:
newest
oldest
Include:
line numbers
double spacing
all authors
publication IDs